SFM
ZVRA icon

Sphera Funds Management’s Zevra Therapeutics ZVRA Stock Holding History

Sphera Funds Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,414
Closed -$147K – 132
2018
Q2 		$147K Buy
+1,414
New +$138K 0.02% 109
2016
Q2 		– Sell
-11,497
Closed -$2.67M – 113
2016
Q1 		$2.67M Hold
11,497
– – 0.58% 33
2015
Q4 		$3.65M Sell
11,497
-1,278
-10% -$347K 0.53% 36
2015
Q3 		$3.96M Sell
12,775
-2,069
-14% -$634K 0.51% 40
2015
Q2 		$4.36M Buy
+14,844
New +$3.24M 0.43% 53

Other funds holding ZVRA

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sphera Funds Management's ZVRA Position: Q3 2018 in Review

Sphera Funds Management sold out of Zevra Therapeutics (ZVRA) in Q3 2018, closing a stake of 1,414 shares — an estimated $147K sold.

Sphera Funds Management first reported a position in ZVRA in Q2 2015 and held it in 5 quarters. The position peaked at $4.36M in Q2 2015. 33 funds tracked by Wall St. Rank hold ZVRA as of Q3 2018.

  • Sphera Funds Management reported no remaining Zevra Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Sphera Funds Management sold 1,414 Zevra Therapeutics shares in Q3 2018, an estimated $147K.
  • Sphera Funds Management first reported a position in Zevra Therapeutics in Q2 2015 and held it in 5 quarters.
  • Sphera Funds Management's Zevra Therapeutics position peaked at $4.36M in Q2 2015.
  • 33 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2018.

Based on Sphera Funds Management's 13F filing for Q3 2018, filed 14 Nov 2018.